Kim E. Nichols

St. Jude Children's Research Hospital — United States

Immunology and Microbiology · Life Sciences

80h-index24.9kcitations616works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(122), Cancer-related Molecular Pathways(93), Cancer Genomics and Diagnostics(91), Autoimmune and Inflammatory Disorders Research(74), Childhood Cancer Survivors' Quality of Life(71)

Publications614 total

Supplementary Data- Tables TS1-6 from Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management
2025Open Access
Supplementary fig 3 from Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management
2025Open Access
Supplementary fig 2 from Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management
2025Open Access
Supplementary fig 1 from Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management
2025Open Access
Supplementary Methods MS1 from Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management
2025Open Access
PD-1 Expression Promotes Immune Evasion in B-ALL
Hematology Reports·2025Open Access
Histiocyte Society blueprint for hemophagocytic lymphohistiocytosis research: deciphering underlying disease mechanisms to optimize diagnosis and therapy
Haematologica·2025· 3 citedOpen Access
Investigation of DNA Damage Response Genes Validates the Role of DNA Repair in Pediatric Cancer Risk and Identifies <i>SMARCAL1</i> as a Novel Osteosarcoma Predisposition Gene
Journal of Clinical Oncology·2025· 2 citedOpen Access
Clinical experience of using integrated whole genome and transcriptome sequencing as a framework for pediatric and adolescent acute myeloid leukemia diagnosis and risk assessment
Leukemia·2025· 2 citedOpen Access
Inferring germline pharmacogenomics from tumor transcriptome
Pharmacogenetics and Genomics·2025
Supplemental Table 4 from Contribution of Germline Predisposition to Pediatric Thyroid Cancer
2025Open Access
Supplemental Table 2 from Contribution of Germline Predisposition to Pediatric Thyroid Cancer
2025Open Access
Supplemental Table 3 from Contribution of Germline Predisposition to Pediatric Thyroid Cancer
2025Open Access
Supplemental Table 1 from Contribution of Germline Predisposition to Pediatric Thyroid Cancer
2025Open Access
Supplemental Table 5 from Contribution of Germline Predisposition to Pediatric Thyroid Cancer
2025Open Access
Insights into germline predisposition to pediatric lymphoid malignancies
Leukemia·2025Open Access
Supplemental Table 2 from Contribution of Germline Predisposition to Pediatric Thyroid Cancer
2025Open Access
Data from Contribution of Germline Predisposition to Pediatric Thyroid Cancer
2025Open Access
Supplemental Table 3 from Contribution of Germline Predisposition to Pediatric Thyroid Cancer
2025Open Access
Supplemental Table 1 from Contribution of Germline Predisposition to Pediatric Thyroid Cancer
2025Open Access
page 1 of 31Next →

Frequent Co-authors

Stuart G. Tangye(7), Charles G. Mullighan(7), Jinghui Zhang(6), Gang Wu(6), Ching‐Hon Pui(6), Michael B. Jordan(6), Jan‐Inge Henter(5), Kai Lehmberg(5), S. Cindy(5), Michael N. Edmonson(4), Shuoguo Wang(4), Elaine R. Mardis(4), James R. Downing(4), AnnaCarin Horne(4), Daniel A. Haber(4), Jennifer L. Cannons(4), Gary A. Koretzky(4), Mignon L. Loh(4), Meenakshi Devidas(4), Stephen P. Hunger(4)